Article
Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Aug 2017
Akbay Esra A, Koyama Shohei, Liu Yan, Dries Ruben, Bufe Lauren E, Silkes Michael, Alam Md Maksudul, Magee Dillon M, Jones Robert, Jinushi Masahisa, Kulkarni Meghana, Carretero Julian, Wang Xiaoen, Warner-Hatten Tiquella, Cavanaugh Jillian D, Osa Akio, Kumanogoh Atsushi, Freeman Gordon J, Awad Mark M, Christiani David C, Bueno Raphael, Hammerman Peter S, Dranoff Glenn, Wong Kwok-Kin
Abstract excerpt
INTRODUCTION: Proinflammatory cytokine interleukin-17A (IL-17A) is overexpressed in a subset of patients with lung cancer. We hypothesized that IL-17A promotes a protumorigenic inflammatory phenotype and inhibits antitumor immune responses. METHODS: We generated bitransgenic mice expressing a conditional IL-17A allele along with conditional KrasG12D and performed immune phenotyping of mouse lungs, a survival...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
